(Q44602395)

4 December 2017

title

Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study). (English)

1 reference

4 December 2017

1 reference

1 reference

Masashi Fujii

1

1 reference

4 December 2017

0

series ordinal

2

1 reference

4 December 2017

publication date

14 June 2008

1 reference

International Journal of Clinical Oncology

4 December 2017

published in

1 reference

4 December 2017

volume

13

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

201-205

1 reference

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

4 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0775-1

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0775-1

Clinical cardiac tolerability of trastuzumab

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10147-008-0775-1

[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)]

21 January 2018

1 reference

12 December 2020

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

12 December 2020

Rational design of new tumoractivated cytotoxic agents

1 reference

12 December 2020

Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer

1 reference

12 December 2020

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

1 reference

12 December 2020

Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer

1 reference

12 December 2020

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

12 December 2020

Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group

1 reference

12 December 2020

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

12 December 2020

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

1 reference

12 December 2020

Chemotherapy of gastric cancer

1 reference

12 December 2020

Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients

1 reference

12 December 2020

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.

1 reference

12 December 2020

10.1007/S10147-008-0775-1

Identifiers

DOI

1 reference

release_cxb63sykvvbc5id7lj27wtepii

4 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cxb63sykvvbc5id7lj27wtepii

24 November 2022

mapped directly with Wikidata item

1 reference